Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell ...

CAR2119’s single-infusion approach offers cost and compliance advantages, though its competitors maintain strong commercial ...

In a breakthrough cancer therapy development, scientists at MIT and Harvard Medical School created a new way of designing ...

The embryo-like model could help scientists test new drugs, create stem cells for transplants and research blood disorders ...

Aera Therapeutics Presents Preclinical Data and Announces Nomination of First Development Candidate, AERA-109, a Targeted In Vivo CAR-T Therapy for B Cell-mediated Autoimmune Diseases Preclinical data ...

Nutrition experts share the best time to take vitamin B, plus who should be supplementing, how much you need, and what all ...

Scientists have found a new way to stop cancer growth without damaging healthy cells. Researchers from the Francis Crick Institute and Vividion Therapeutics discovered a compound that blocks the ...

Living with an autoimmune disease often means navigating a lifelong, complex condition. A recent study estimates that ...

MIT and Harvard scientists have designed an advanced type of immune cell called a CAR-NK cell that can destroy cancer while ...

Scientists have long suspected connections between heredity and disease, dating back to Hippocrates, who observed certain ...